Wolverine Trading
MYGN icon

Wolverine Trading’s Myriad Genetics MYGN Stock Holding History

Wolverine Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$145K Buy
20,000
+10,000
+100% +$59.4K ﹤0.01% 5068
2025
Q2 		$52.5K Buy
+10,000
New +$59.1K ﹤0.01% 4338
2022
Q1 		– Sell
-8,000
Closed -$221K – 6093
2021
Q4 		$221K Buy
+8,000
New +$232K ﹤0.01% 4563
2021
Q3 		– Sell
-15,200
Closed -$463K – 6706
2021
Q2 		$463K Buy
+15,200
New +$439K ﹤0.01% 3814
2021
Q1 		– Sell
-14,300
Closed -$281K – 6228
2020
Q4 		$281K Sell
14,300
-3,900
-21% -$63K ﹤0.01% 3829
2020
Q3 		$232K Buy
18,200
+4,400
+32% +$55.7K ﹤0.01% 3702
2020
Q2 		$152K Sell
13,800
-7,300
-35% -$104K ﹤0.01% 3972
2020
Q1 		$306K Sell
21,100
-7,400
-26% -$156K ﹤0.01% 3194
2019
Q4 		$756K Buy
28,500
+3,300
+13% +$90.8K ﹤0.01% 2681
2019
Q3 		$717K Sell
25,200
-17,800
-41% -$519K ﹤0.01% 2260
2019
Q2 		$1.2M Buy
+43,000
New +$1.21M ﹤0.01% 1892
2018
Q4 		– Sell
-33,400
Closed -$1.54M – 5039
2018
Q3 		$1.54M Sell
33,400
-12,100
-27% -$538K ﹤0.01% 1915
2018
Q2 		$1.34M Hold
45,500
– – ﹤0.01% 1950
2018
Q1 		$1.34M Buy
45,500
+7,500
+20% +$254K ﹤0.01% 1950
2017
Q4 		$1.3M Buy
38,000
+4,000
+12% +$135K ﹤0.01% 1933
2017
Q3 		$1.23M Sell
34,000
-18,900
-36% -$539K ﹤0.01% 1714
2017
Q2 		$1.36M Buy
52,900
+42,100
+390% +$894K 0.01% 1508
2017
Q1 		$206K Buy
+10,800
New +$191K ﹤0.01% 3496
2016
Q4 		– Sell
-15,200
Closed -$315K – 4885
2016
Q3 		$315K Buy
+15,200
New +$386K ﹤0.01% 3166

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's MYGN Position: Q3 2019 in Review

Wolverine Trading sold out of Myriad Genetics (MYGN) in Q3 2019, closing a stake of 9,343 shares — an estimated $272K sold.

Wolverine Trading first reported a position in MYGN in Q2 2016 and held it in 2 quarters. The position peaked at $706K in Q2 2016. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2019.

  • Wolverine Trading reported no remaining Myriad Genetics position as of Q3 2019 after selling out during the quarter.
  • Wolverine Trading sold 9,343 Myriad Genetics shares in Q3 2019, an estimated $272K.
  • Wolverine Trading first reported a position in Myriad Genetics in Q2 2016 and held it in 2 quarters.
  • Wolverine Trading's Myriad Genetics position peaked at $706K in Q2 2016.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2019.

Based on Wolverine Trading's 13F filing for Q3 2019, filed 14 Nov 2019.